Though serum tumor markers, such as AFP and tumor-associated antigens (TAAs), are engaging alternatives for monitoring and early diagnosis of hepatocellular carcinoma, their sensitivities and specificities remain disappointing. The gene discussed is AFP; the disease is hepatocellular carcinoma.